Type 2 diabetes mellitus characteristics affect hepatocellular carcinoma development in chronic hepatitis B patients with cirrhosis

doi:10.12998/wjcc.v11.i5.1009

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2940)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

WORD

HTML

1102

Figures (1-2)

314

Tables (1-3)

230

Sum=1759

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

181

Download

430

Sum=611

Publishing Process of This Article

Item

Count

Browse

135

Download

435

Sum=570

Feb 16, 2023 (publication date) through Jul 24, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Feb 16, 2023; 11(5): 1009-1018
Published online Feb 16, 2023. doi: 10.12998/wjcc.v11.i5.1009

Full Size Figure Download Figure

Figure 2 Correlation between type 2 diabetes mellitus and hepatocellular carcinoma development across different subgroups. The results showed that type 2 diabetes mellitus and hepatocarcinogenesis were significantly correlated in the male subgroup, the non-smoker subgroup, the no alcohol abuse subgroup, the hepatitis B surface antigen > 2.0 log IU/mL subgroup, and the no antiviral treatment subgroup (P < 0.05). AFP: Alpha-fetoprotein; CI: Confidence interval; HBV: Hepatitis B virus; HBeAg: Hepatitis B e-antigen.

Citation: Li MY, Li TT, Li KJ, Zhou C. Type 2 diabetes mellitus characteristics affect hepatocellular carcinoma development in chronic hepatitis B patients with cirrhosis. World J Clin Cases 2023; 11(5): 1009-1018
URL: https://www.wjgnet.com/2307-8960/full/v11/i5/1009.htm
DOI: https://dx.doi.org/10.12998/wjcc.v11.i5.1009